中药通过SIRT1信号通路干预糖尿病肾病基础研究进展

Progress in Basic Research on the Intervention of Chinese Materia Medica in Diabetes Kidney Disease through SIRT1 Signaling Pathway

糖尿病肾病(DKD)是终末期肾脏病的主要原因。沉默信息调节因子1(SIRT1)蛋白在糖尿病肾病的发生发展过程中发挥关键作用。中药干预DKD表现出独特优势。本文围绕SIRT1信号通路及主要分子调节机制,梳理中药调控SIRT1在足细胞、氧化应激和炎症反应中作用,发现中药单体及中药复方可通过靶向SIRT1调控PGC-1α信号通路、Nrf2/ARE信号通路、AMPK信号通路、NF-κB p65信号通路及PI3K/AKT/FoxO1信号通路,发挥抑制细胞凋亡、改善线粒体自噬、抑制炎症反应等药理作用,从而干预DKD,可为相关研究提供参考。

Diabetic kidney disease(DKD)is the leading cause of end-stage renal disease.Chinese materia medica shows unique advantages in intervening DKD.Silent information regulator 1(SIRT1)protein plays a vital role in the occurrence and development of DKD.This article was about the SIRT1 signaling pathway and the main molecular regulatory mechanisms to sort out the role of Chinese materia medica in regulating SIRT1 in podocytes,oxidative stress and inflammatory response.It was found that Chinese materia medica monomers and compounds were capable of regulating the PGC-1αsignaling pathway,Nrf2/ARE signaling pathway,AMPK signaling pathway,NF-κB p65 signaling pathway,and PI3K/AKT/FoxO1 signaling pathway by targeting SIRT1,exerting pharmacological effects such as inhibiting cell apoptosis,improving mitophagy,inhibiting inflammatory response,etc.,thus intervening in DKD,which can provide reference for relevant research.